WPG Advisers »

Keros Therapeutics shares owned by WPG Advisers

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by WPG Advisers from 13F filings

Historical chart of WPG Advisers investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by WPG Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by WPG Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $489 24 20.38
2025-09-30 $379 24 15.83

More positions owned by WPG Advisers

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Msci Intl Qualty (IQLT)
First Tr Exchange Traded Rba Indl Etf (AIRR)
Vanguard World Mega Cap Val Etf (MGV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
John Hancock Exchange Traded Multifactor Mi (JHMM)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Amazon (AMZN)
Apple (AAPL)
First Tr Exchange-traded Smid Risng Etf (SDVY)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)

View all positions for WPG Advisers

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics